rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    DHR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Danaher Targets Faster Growth With Acquisitions, AI and a Diagnostics Push
      19h agoYahoo FinanceDHR
      Danaher Corp. stock underperforms Tuesday when compared to competitors
      Nov 17MarketWatchDHR
      Danaher at Jefferies Global Healthcare Conference: growth plan takes shape
      Nov 17Investing.comDHRJEF
      Danaher (DHR) Is A Key Supplier In Fast Growing Bioprocessing Markets
      Nov 12Yahoo FinanceDHR
      Danaher’s Cepheid business to lay off 67 people in California
      Nov 11Yahoo FinanceDHR
      Insider Move: Matthew McGrew Exercises Options, Realizing $2.56M At Danaher
      Nov 11BenzingaDHR
      Danaher CEO Sees Faster Growth Ahead, With AI and Acquisitions in Focus
      Nov 10Yahoo FinanceDHR
      Danaher at UBS Global Healthcare Conference: growth plan takes shape
      Nov 9Investing.comDHRUBS
      Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains
      Nov 6MarketWatchDHR
      Danaher (DHR) Stock Fair Value Rises After Higher Analyst Targets And Q3 Commentary

      Danaher is back in focus as analysts cluster around higher price targets, with several recent updates now sitting in the US$260 to US$275 range. These moves line up with research that highlights the company’s 2027 core growth framing, Q3 2026 trends, and how execution could feed through to margins, organic growth, and Danaher’s P/E multiple over time. Read on to see what is driving the shift in the analyst narrative and how you can track the story from here. Analyst Price Targets don't always...

      Nov 5Yahoo FinanceDHR
      Danaher (DHR) Wins FDA Clearance For Hemorrhagic Fever Test With Four Virus Detection
      Nov 4Yahoo FinanceDHR
      Danaher (DHR) Stock Looks Fully Priced Despite Its 18% Three Year Gain

      Danaher has delivered an 18.1% gain over the past three years, and the question now is whether that share price level matches what its cash flows can reasonably support. Recent product clearances in its diagnostics and life sciences units add fresh information for investors who are trying to anchor Danaher’s valuation to the cash coming off the business rather than the headlines. The stock’s 18.1% return over three years places greater focus on whether the underlying cash generation is...

      Nov 4Yahoo FinanceDHR
      Learn Why The Bull Case For Danaher (DHR) Could Change Following FDA Test Clearance

      Danaher reported third quarter 2026 sales of US$6,554 million and net income of US$1,235 million, alongside FDA clearance for Beckman Coulter Diagnostics' Access MeMed BV rapid assay that distinguishes bacterial from viral infections in about 15 minutes and fits into existing lab workflows. The Access MeMed BV test gives Danaher another clinically meaningful diagnostic tool that can support antimicrobial stewardship efforts and potentially deepen consumables usage on its installed analyzer...

      Nov 4Yahoo FinanceDHR
      Danaher (DHR), Why Is It Drawing Fresh Attention Today?

      Danaher (DHR) is back in focus after U.S. regulators cleared the Access MeMed BV assay, a rapid test that helps clinicians distinguish bacterial from viral infections and potentially curb unnecessary antibiotic use. That regulatory win comes during a busy period for Danaher. Third quarter results on 21 October 2026 showed higher sales and earnings compared with a year earlier, and management lined up conference appearances at UBS and Jefferies to keep the story in front of healthcare...

      Nov 4Yahoo FinanceDHR
      Danaher wins FDA nod for Xpert Hemorrhagic Fever Panel (DHR)

      Danaher (DHR) unit Cepheid wins FDA approval for Xpert Hemorrhagic Fever Panel to detect Ebola and several other hemorrhagic fever viruses. REad more here.

      Nov 3Seeking AlphaDHR
      What Are Danaher Investors Betting On?
      Nov 3Yahoo FinanceDHR
      Danaher to Present at UBS Global and Jefferies Global Healthcare Conferences
      Nov 2Yahoo FinanceDHR
      Danaher Corp. stock underperforms Friday when compared to competitors
      Oct 30MarketWatchDHR
      At Danaher, Christopher Bouda Chooses To Exercise Options, Resulting In $1.23M
      Oct 30BenzingaDHR
      Matthew McGrew At Danaher Capitalizes: Options Exercised, Resulting In $2.45M
      Oct 30BenzingaDHR
      Danaher (DHR) Upgraded to Buy: Here's Why
      Oct 27Yahoo FinanceDHR
      Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year
      Oct 26BenzingaEAGLDHREQTY
      What Does Danaher (DHR) FDA Clearance For AI AFib Detection Mean Now?
      Oct 22Yahoo FinanceDHR
      Danaher Posts First Earnings Under New CEO; Emphasizes Need For Improved Execution, Innovation
      Oct 22BenzingaDHR
      Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
      Oct 22BenzingaDHR
      UBS reiterates Danaher stock Buy rating on Q3 results and outlook
      Oct 22Investing.comDHR
      Stifel raises Danaher stock price target to $260 on growth outlook
      Oct 22Investing.comDHR
      Danaher (DHR) Q3 Earnings Fuel Stock Gains On Margin Expansion
      Oct 22Yahoo FinanceDHR
      Danaher Q3 Recap: Decent Results, Still A Hold (NYSE:DHR)
      Oct 22Seeking AlphaDHR
      DHR Q3 deep dive: execution focus and AI strategy underpin improved outlook
      Oct 22Yahoo FinanceDHR
      Danaher (DHR) Stock Fair Value Edges Higher After Analysts Lift Targets
      Oct 22Yahoo FinanceDHR
      Why Danaher Stock Bounced Higher Today | The Motley Fool

      The conglomerate posted its latest set of quarterly earnings that morning.

      Oct 21The Motley FoolDHR
      Danaher Corp. stock outperforms competitors on strong trading day
      Oct 21MarketWatchDHR
      Danaher Corp (DHR) (Q3 2026) Earnings Call Highlights: Core Growth Accelerates to 5. ...
      Oct 21Yahoo FinanceDHR
      Danaher: 3 Key Takeaways for Long-Term Investors
      Oct 21Yahoo FinanceDHR
      Danaher (DHR) Q3 2026 Earnings Call Transcript
      Oct 21The Globe and MailDHR
      Danaher Q3 Review: Interested To See What The New Management Will Bring (NYSE:DHR)

      Danaher delivered mixed Q3 results, with revenue up 8.3% y/y but growth driven mainly by acquisitions and tariff refunds. Read more on DHR stock here.

      Oct 21Seeking AlphaDHR
      Danaher Corporation Q3 2026 Earnings Call Summary
      Oct 21Yahoo FinanceDHR
      Danaher Jumps 4% on Q3 Beat: “Improving Trends” Across Its End Markets
      Oct 21Yahoo FinanceDHR
      Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves
      Oct 21BenzingaDHR
      Abbott to Separate Nutrition Business as Quarterly Results, Along With Thermo Fisher, Danaher Rise Annually
      Oct 21Yahoo FinanceABTDHRTMO
      Medical Giants Bound Higher, Reversing Third-Quarter Worries

      Thermo Fisher and Danaher stocks reversed higher Wednesday after reporting third-quarter metrics and full-year guidance.

      Oct 21Investor's Business DailyDHRTMO
      Danaher Q3 Earnings Call Highlights
      Oct 21Yahoo FinanceDHR
      Danaher Q3 2026 slides: strong margins offset respiratory headwinds
      Oct 21Investing.comDHR
      DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line

      Danaher's third-quarter earnings beat estimates by 9.9%, driven by stronger Biotechnology profitability, while it raised its 2026 adjusted earnings outlook.

      Oct 21Yahoo FinanceDHR
      Earnings call transcript: Danaher tops Q3 2026 estimates but shares fall premarket
      Oct 21Investing.comDHR
      Danaher Q3 2026 Earnings Call Transcript
      Oct 21BenzingaDHR
      Strong Price Rally Validates Danaher’s (DHR) Undervalued Entry Point in Core Diagnostics Engine
      Oct 21Yahoo FinanceDHR
      Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say
      Oct 21Yahoo FinanceDHR
      Danaher stock drops after Q3 revenue miss (DHR:NYSE)
      Oct 21Seeking AlphaDHR

      This is the newest page. Registered accounts read further back.